Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

VVOS Vivos Therapeutics Inc

2,285

0,105 (4,82%)

Zuletzt aktualisiert: 16:47:49

Verzögert um 15 Minuten

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Article too big to display. Click here to view on the SEC website

Vivos Therapeutics (NASDAQ:VVOS)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Vivos Therapeutics Charts.

Vivos Therapeutics (NASDAQ:VVOS)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Vivos Therapeutics Charts.

News Vivos Therapeutics Inc

Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model
Donnerstag 27 Juni 2024 (4 Stunden vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 14 Juni 2024 (2 Wochen vor) • Edgar (US Regulatory)

Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance
Mittwoch 12 Juni 2024 (2 Wochen vor) • GlobeNewswire Inc.

Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote “FOR” Re-Election of Its Highly Qualified Directors
Montag 20 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 17 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 15 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 14 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
Dienstag 14 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
Dienstag 14 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
Dienstag 9 April 2024 (3 Monate vor) • GlobeNewswire Inc.

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
Donnerstag 28 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
Donnerstag 28 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Vivos Therapeutics Inc News-Artikel

Euro Corp Bond UCITS ETF

Synergy Empire (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen